Abbott Current Deferred Revenue from 2010 to 2025
| ABT Stock | USD 126.78 0.64 0.50% |
Current Deferred Revenue | First Reported 1993-12-31 | Previous Quarter 562 M | Current Value 601 M | Quarterly Volatility 1.5 B |
Check Abbott Laboratories financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Abbott Laboratories' main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.4 B, Interest Expense of 531 M or Selling General Administrative of 6.4 B, as well as many indicators such as Price To Sales Ratio of 4.9, Dividend Yield of 0.0186 or PTB Ratio of 2.63. Abbott financial statements analysis is a perfect complement when working with Abbott Laboratories Valuation or Volatility modules.
Abbott | Current Deferred Revenue |
Latest Abbott Laboratories' Current Deferred Revenue Growth Pattern
Below is the plot of the Current Deferred Revenue of Abbott Laboratories over the last few years. It is revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends. Abbott Laboratories' Current Deferred Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Abbott Laboratories' overall financial position and show how it may be relating to other accounts over time.
| Current Deferred Revenue | 10 Years Trend |
|
Current Deferred Revenue |
| Timeline |
Abbott Current Deferred Revenue Regression Statistics
| Arithmetic Mean | 309,736,875 | |
| Geometric Mean | 259,437,691 | |
| Coefficient Of Variation | 71.74 | |
| Mean Deviation | 161,809,062 | |
| Median | 188,000,000 | |
| Standard Deviation | 222,208,856 | |
| Sample Variance | 49376.8T | |
| Range | 784.3M | |
| R-Value | (0.75) | |
| Mean Square Error | 23340T | |
| R-Squared | 0.56 | |
| Significance | 0.0009 | |
| Slope | (34,890,235) | |
| Total Sum of Squares | 740651.6T |
Abbott Current Deferred Revenue History
About Abbott Laboratories Financial Statements
Abbott Laboratories shareholders use historical fundamental indicators, such as Current Deferred Revenue, to determine how well the company is positioned to perform in the future. Although Abbott Laboratories investors may analyze each financial statement separately, they are all interrelated. The changes in Abbott Laboratories' assets and liabilities, for example, are also reflected in the revenues and expenses on on Abbott Laboratories' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 156.6 M | 148.8 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Abbott Stock Analysis
When running Abbott Laboratories' price analysis, check to measure Abbott Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abbott Laboratories is operating at the current time. Most of Abbott Laboratories' value examination focuses on studying past and present price action to predict the probability of Abbott Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abbott Laboratories' price. Additionally, you may evaluate how the addition of Abbott Laboratories to your portfolios can decrease your overall portfolio volatility.